by The global Ophthalmic Ultrasound Devices market size is expected to be worth around US$ 887.7 million by 2030, according to a new report by Vision Research Reports.
The global Ophthalmic Ultrasound Devices market size was valued at US$ 487.50 million in 2020 and is anticipated to grow at a CAGR of 9.36% during forecast period 2021 to 2030.
Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/39044
Growth Factors
Increasing incidence of diabetes, rising prevalence of ophthalmic disorders, such as cataract and proliferative diabetic retinopathy, growing awareness about cataract surgeries, and the introduction of technologically advanced ophthalmic ultrasounds are among the major factors anticipated to drive the market during the forecast period.
The rising burden of ophthalmic ailments, such as retinal & cataract detachments, and increased demand for effective and efficient imaging tools are further expected to drive the market growth. In addition, numerous novel product launches and technological advancements are expected to contribute to the market growth during the forecast period.
The introduction of advanced technology with integrated scanning features is anticipated to replace the current conventional devices. An increasing number of non-profit as well as private Ambulatory Surgical Centers(ASCs) and ophthalmic clinics in developing countries is expected to play an important role in boosting the global market growth.
Report Coverage
| Report Scope | Details |
| Market Size | US$ 887.7 million by 2030 |
| Growth Rate | CAGR of 9.36% From 2021 to 2030 |
| Base Year | 2021 |
| Forecast Period | 2021 to 2030 |
| Segments Covered | Product, Mobility, End-use |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Companies Mentioned | Halma plc; Nidek Co.Ltd.; Quantel Medical; Optos; Escalon Medical Corp.; Appasamy Associates; MicroMedical Devices; DGH Technology; Ellex; Carl Zeiss Meditech |
By Product Analysis
Based on product, the market is segmented into A-scan, B-scan, combined, pachymeter, and ultrasound biomicroscope. The A-scan product segment held the largest market share of 29.6% in 2020. High usage of A-scan devices for pre-operative visualization of a detached retina in cases, such as vitreous hemorrhage, peri-orbital trauma, or lens opacification, is one of the major factors anticipated to foster the segment growth.
The B-scan segment is expected to grow at a CAGR of 9.30% during the forecast period. The increasing reach of these compact, affordable, lightweight, and multifunctional devices is expected to fuel the segment growth. The B-scan ultrasound system is two-dimensional as well as a cross-section brightness scan.
By Mobility Analysis
Based on mobility, the market is classified into standalone and portable/handheld devices. The standalone devices segment held the largest revenue share of more than 54% in 2020 owing to the factors, such as affordability and easy availability & handling.
The portable devices segment is anticipated to grow at the fastest CAGR during the forecast period. Space constraints in ophthalmologist clinics, frequent introduction of portable ocular ultrasounds with advanced features at affordable pricing, and growing standards of healthcare across the globe are expected to aid the growth of this segment.
By End-use Analysis
Based on end-use, the global market is segmented into Ambulatory Surgical Centers (ASCs), hospitals, and ophthalmic clinics. The hospitals segment accounted for the largest market share of more than 35% in 2020.
Enormous patient pool, availability of advanced technology, and favorable government programs are other key factors predicted to drive the segment growth over the coming years.
The ophthalmic clinics segment had a considerable market share in 2020. The growing number of ophthalmologists in developing countries is expected to have a significant impact on the market growth with a steep rise in the number of ophthalmic clinics.
By Regional Analysis
North America dominated the market with the largest revenue share of 38% owing to the high demand for technologically advanced medical devices, such as A-scan, B-scan, and combined devices.
Europe accounted for the second-largest share in 2020. The presence of several ophthalmology societies including the European Society of Cataract and Refracting Surgeons as well as the European Society of Ophthalmology (ESC)
Asia Pacific is anticipated to grow at the fastest CAGR over the forecast period owing to high unmet needs along with developing healthcare infrastructure, especially in Japan and India. Furthermore, the presence of domestic manufacturers & suppliers and the prevalence of ophthalmic disorders are expected to drive the regional market.
Key Players
- Halma plc
- NIDEK CO. Ltd.
- Quantel Medical
- Optos
- Escalon Medical Corp
- Appasamy Associates
- MicroMedical Devices
- DGH Technology
- Ellex
- Carl Zeiss Meditech
Market Segmentation
- By Product
- A-Scan
- B-Scan
- Combined
- Pachymeter
- Ultrasound Bio Microscope
- By Mobility
- Standalone
- Portable
- By End-use
- Hospitals
- Ambulatory Surgical Centers
- Ophthalmic Clinics
- Others
- Regional
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Italy
- Spain
- Asia Pacific
- China
- Japan
- India
- Thailand
- South Korea
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Middle East and Africa
- Saudi Arabia
- South Africa
- UAE
- North America
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Ophthalmic Ultrasound Devices Market, By Capacitor
7.1. Ophthalmic Ultrasound Devices Market, by Capacitor, 2021-2030
7.1.1. A-Scan
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. B-Scan
7.1.2.1. Market Revenue and Forecast (2017-2030)
7.1.3. Combined
7.1.3.1. Market Revenue and Forecast (2017-2030)
7.1.4. Pachymeter
7.1.4.1. Market Revenue and Forecast (2017-2030)
7.1.5. Ultrasound Bio Microscope
7.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 8. Global Ophthalmic Ultrasound Devices Market, By Mobility
8.1. Ophthalmic Ultrasound Devices Market, by Mobility, 2021-2030
8.1.1. Standalone
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Portable
8.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Ophthalmic Ultrasound Devices Market, By End User
9.1. Ophthalmic Ultrasound Devices Market, by End User, 2021-2030
9.1.1. Hospitals
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Ambulatory Surgical Centers
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Ophthalmic Clinics
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Ophthalmic Ultrasound Devices Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Capacitor (2017-2030)
10.1.2. Market Revenue and Forecast, by Mobility (2017-2030)
10.1.3. Market Revenue and Forecast, by End User (2017-2030)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Capacitor (2017-2030)
10.1.4.2. Market Revenue and Forecast, by Mobility (2017-2030)
10.1.4.3. Market Revenue and Forecast, by End User (2017-2030)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Capacitor (2017-2030)
10.1.5.2. Market Revenue and Forecast, by Mobility (2017-2030)
10.1.5.3. Market Revenue and Forecast, by End User (2017-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Capacitor (2017-2030)
10.2.2. Market Revenue and Forecast, by Mobility (2017-2030)
10.2.3. Market Revenue and Forecast, by End User (2017-2030)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Capacitor (2017-2030)
10.2.4.2. Market Revenue and Forecast, by Mobility (2017-2030)
10.2.4.3. Market Revenue and Forecast, by End User (2017-2030)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Capacitor (2017-2030)
10.2.5.2. Market Revenue and Forecast, by Mobility (2017-2030)
10.2.5.3. Market Revenue and Forecast, by End User (2017-2030)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Capacitor (2017-2030)
10.2.6.2. Market Revenue and Forecast, by Mobility (2017-2030)
10.2.6.3. Market Revenue and Forecast, by End User (2017-2030)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Capacitor (2017-2030)
10.2.7.2. Market Revenue and Forecast, by Mobility (2017-2030)
10.2.7.3. Market Revenue and Forecast, by End User (2017-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Capacitor (2017-2030)
10.3.2. Market Revenue and Forecast, by Mobility (2017-2030)
10.3.3. Market Revenue and Forecast, by End User (2017-2030)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Capacitor (2017-2030)
10.3.4.2. Market Revenue and Forecast, by Mobility (2017-2030)
10.3.4.3. Market Revenue and Forecast, by End User (2017-2030)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Capacitor (2017-2030)
10.3.5.2. Market Revenue and Forecast, by Mobility (2017-2030)
10.3.5.3. Market Revenue and Forecast, by End User (2017-2030)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Capacitor (2017-2030)
10.3.6.2. Market Revenue and Forecast, by Mobility (2017-2030)
10.3.6.3. Market Revenue and Forecast, by End User (2017-2030)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Capacitor (2017-2030)
10.3.7.2. Market Revenue and Forecast, by Mobility (2017-2030)
10.3.7.3. Market Revenue and Forecast, by End User (2017-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Capacitor (2017-2030)
10.4.2. Market Revenue and Forecast, by Mobility (2017-2030)
10.4.3. Market Revenue and Forecast, by End User (2017-2030)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Capacitor (2017-2030)
10.4.4.2. Market Revenue and Forecast, by Mobility (2017-2030)
10.4.4.3. Market Revenue and Forecast, by End User (2017-2030)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Capacitor (2017-2030)
10.4.5.2. Market Revenue and Forecast, by Mobility (2017-2030)
10.4.5.3. Market Revenue and Forecast, by End User (2017-2030)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Capacitor (2017-2030)
10.4.6.2. Market Revenue and Forecast, by Mobility (2017-2030)
10.4.6.3. Market Revenue and Forecast, by End User (2017-2030)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Capacitor (2017-2030)
10.4.7.2. Market Revenue and Forecast, by Mobility (2017-2030)
10.4.7.3. Market Revenue and Forecast, by End User (2017-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Capacitor (2017-2030)
10.5.2. Market Revenue and Forecast, by Mobility (2017-2030)
10.5.3. Market Revenue and Forecast, by End User (2017-2030)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Capacitor (2017-2030)
10.5.4.2. Market Revenue and Forecast, by Mobility (2017-2030)
10.5.4.3. Market Revenue and Forecast, by End User (2017-2030)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Capacitor (2017-2030)
10.5.5.2. Market Revenue and Forecast, by Mobility (2017-2030)
10.5.5.3. Market Revenue and Forecast, by End User (2017-2030)
Chapter 11. Company Profiles
11.1. Halma plc
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. NIDEK CO. Ltd.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Quantel Medical
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Optos
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Escalon Medical Corp
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Appasamy Associates
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. MicroMedical Devices
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. DGH Technology
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Ellex
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Carl Zeiss Meditech
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/39044
Contact Us:
Vision Research Reports
Call: +1 9197 992 333
